In the BioHarmony Drug Report Database
Viramune (nevirapine) is a small molecule pharmaceutical. Nevirapine was first approved as Viramune on 1996-06-21. It is used to treat acquired immunodeficiency syndrome and HIV infections in the USA. It has been approved in Europe to treat HIV infections. Viramune’s patent is valid until 2029-03-12 (FDA).
Image (chem structure or protein)